Chapter 18. Human Cerebrospinal Fluid

  1. Dr. Jean-Charles Sanchez,
  2. Dr. Garry L. Corthals,
  3. Prof. Dr. Denis F. Hochstrasser
  1. Dr. Pia Davidsson1,
  2. Dr. Michael G. Harrington2

Published Online: 20 SEP 2004

DOI: 10.1002/3527601562.ch18

Biomedical Applications of Proteomics

Biomedical Applications of Proteomics

How to Cite

Davidsson, P. and Harrington, M. G. (2004) Human Cerebrospinal Fluid, in Biomedical Applications of Proteomics (eds J.-C. Sanchez, G. L. Corthals and D. F. Hochstrasser), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527601562.ch18

Editor Information

  1. Biomedical Proteomics Research Group, Laboratoire Central de Chimie Clinique, Hopitaux Universitaires de Genève, 24, rue Micheli-du-Crest, 1211 Genève 14, Switzerland

Author Information

  1. 1

    Experimental Medicine/Molecular Sciences, AstraZeneca Molndal R & D, 43083 Molndal, Sweden

  2. 2

    Molecular Neurology Program, Huntington Medical Research Institutes, 99 North El Molino Avenue, Pasadena, CA 91101, USA

Publication History

  1. Published Online: 20 SEP 2004
  2. Published Print: 27 JAN 2004

ISBN Information

Print ISBN: 9783527308071

Online ISBN: 9783527601561

SEARCH

Keywords:

  • cerebrospinal fluid;
  • experimental design;
  • CSF proteomic applications;
  • central nervous system diseases

Summary

  • Introduction

  • Experimental Design

    • Sample Collection and Preparation

  • Two-dimensional Gels of CSF, with Protein Identification by Antibodies, Edman Degradation Chemistry, MALDI/MS or LC/MS of Individual “Spots”

    • Prefractionation of CSF Prior to 2-DE

    • Two-dimensional Liquid-phase Electrophoresis and Other LC-coupled MS Approaches

  • CSF Proteomic Applications in Central Nervous System Diseases

  • Future Challenges

  • References